TABLE 3.
The clinical outcomes of the patient cohorts in our study.
| Clinical outcomes (n = 55) | |
| Failure pattern | 10-year control rate (n [%]) |
| Ipsilateral breast tumor recurrence | 1 (1.82%) |
| Regional nodal failure | 0 |
| Distant metastasis | 1 (1.82%) |
| Disease-free survival | 52 (94.55%) |
| Overall survival | 54 (98.18%) |